Moxifloxacin

Excerpt

Moxifloxacin is a potent fluoroquinolone antibiotic that is effective against a wide range of bacterial infections. Bayer AG developed the drug in the late 1990s, and it received approval from the U.S. Food and Drug Administration (FDA) in 1999 for the treatment of respiratory infections, making it a valuable addition to the antibiotic arsenal due to its broad-spectrum coverage.